Founded by Dr. Gabriel Serrano, a globally recognized dermatologist, Mediderma was the first company to introduce a complete line of chemical peels into the medical and professional skincare market. Today, its treatments are trusted by dermatologists and aesthetic professionals worldwide, addressing a wide range of skin concerns with revolutionary formulations.

With a strong commitment to research, innovation, and education, Mediderma works closely with healthcare professionals to develop products that deliver real, transformative results. Its expertise in nanotechnology and dermocosmetic ensures that active ingredients reach deeper skin layers for maximum efficacy.

Through our collaboration with Sesderma Laboratories, Iberia Pharmaceuticals remains dedicated to bringing Mediderma’s scientifically backed treatments to professionals who seek the highest standards in dermatological care. From advanced peels to specialized skincare protocols, Mediderma continues to redefine the future of professional skincare.